26.07.2021 Health

COVID-19: Ghana in early stages of third wave – Infectious disease professional warns

COVID-19: Ghana in early stages of third wave – Infectious disease professional warns
Listen to article

Dr. John Amoasi, an infectious disease professional, has said there are signs that Ghana is in the early stages of a third wave of the covid-19 pandemic.

Dr. Amoasi, in an interview on the Citi Breakfast Show, said ”looking at the numbers of infections we are recording now and the number of deaths we keep recording, we are, undoubtedly, in the third wave.”

“What makes it a wave is a departure from what it has been over a certain period of time. A wave can be either lower or higher than what it has been before.”

He however noted that “we are not at the peak just yet.”

“If you look at the numbers carefully, we are really on the incline of the wave. We can only tell we are at the peak when the numbers begin to decline,” he added.

He advised the government to tighten the measures put in place to prevent the likelihood of “reaching the peak of a third wave of the virus.”

“My anticipation is that it will go up a little more. I hope it won't translate into deaths. How long it will last, I really can't tell, but looking at what is going on in other countries, we have about two more weeks till we reach the peak, depending on the measures we put in place.”

Meanwhile, President Akufo-Addo, in his 26th update on the measures put in place to reduce the rising COVID-19 cases in the country, indicated that more vaccines will be available in the third quarter of this year.

The President said, “we are expecting through the COVAX facility, one million Pfizer vaccines from the United States of America, 29,670 Pfizer vaccines from the African Union, and 249,000 AstraZeneca vaccines from the United Kingdom.”

He also indicated that the government is in the process of procuring 17 million single doses per person Johnson & Johnson vaccines, through the African Medicine Supply Platform, in this quarter.


ModernGhana Links

Join our Newsletter